Hyperleptinemia, which occurs in obesity-related metabolic disturbances, favors the synthesis of the thyrotropin-releasing hormone via the promotion of the synthesis of the α-melanocyte-stimulating hormone and the activation of the STAT3 transcription factor [12]. The gene discussed is STAT3; the disease is obesity due to melanocortin 4 receptor deficiency.